BIOLASE, Inc. (BIOL)
-NasdaqCM 4.83 
0.11(2.33%) 2:50PM EDT - Nasdaq Real Time Price
| Prev Close: | 4.72 |
|---|
| Open: | 4.75 |
|---|
| Bid: | 4.85 x 400 |
|---|
| Ask: | 4.86 x 100 |
|---|
| 1y Target Est: | 5.66 |
|---|
| Beta: | 2.51 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 4.70 - 4.91 |
|---|
| 52wk Range: | 1.48 - 6.05 |
|---|
| Volume: | 370,644 |
|---|
| Avg Vol (3m): | 467,754 |
|---|
| Market Cap: | 152.01M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.13 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- InPlay: Biolase declares a one-half percent stock dividend payable on June 28, 2013, to stockholders of record on June 14, 2013Briefing.com(Tue, May 21)
- BIOLASE Declares Stock Dividend for 2013 Second QuarterMarketwired(Tue, May 21)
- BIOLASE, INC FinancialsEDGAR Online Financials(Fri, May 17)
- Finding Investment Opportunities in Quality Growth Health Care Companies That the Rest of the Market is OverlookingWall Street Transcript(Fri, May 17)
- NewTom BIOLASE VG3 Panoramic Oral X-Ray System Receives FDA ClearanceMarketwired(Thu, May 16)
- BIOLASE Awarded Two New PatentsMarketwired(Wed, May 15)
- BIOLASE, INC Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online(Mon, May 13)
- Earnings Volatility Drives These Stocks in a New Directionat Wall St. Cheat Sheet(Sun, May 12)
- BIOLASE, INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- BIOLASE Receives FDA Clearance for Orthopedic and Podiatric WaterLase iPlusMarketwired(Wed, May 8)
- BIOLASE's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 8)
- BIOLASE Earnings: Here’s Why Investors Don’t Like These Resultsat Wall St. Cheat Sheet(Tue, May 7)
- BIOLASE Enters Affiliation Agreement With Sun Dental Laboratories, LLCMarketwired(Tue, May 7)
- USPTO Rejects All Claims Subject to Reexamination in the CAO Group's Patent Action Against BIOLASEMarketwired(Tue, May 7)
- Comerica Increases Available Borrowings Under Amended Credit FacilitiesMarketwired(Tue, May 7)
Key Statistics
| Forward P/E (1 yr): | 40.42 |
|---|
| P/S (ttm): | 2.45 |
|---|
| Ex-Dividend Date: | 24-Jun-05 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.04 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.01 |
|---|
| Mean Recommendation*: | 1.5 |
|---|
| PEG Ratio (5 yr expected): | -8.07 |
|---|
Business Summary
BIOLASE, Inc., a biomedical company, develops, manufactures, and markets lasers in dentistry and medicine in the Unites States and internationally. The company offers Waterlase systems for cutting soft and hard tissue; and diode laser systems, whi...
View More